Percutaneous approaches to valve repair for mitral regurgitation
- PMID: 24583296
- DOI: 10.1016/j.jacc.2014.01.039
Percutaneous approaches to valve repair for mitral regurgitation
Abstract
Percutaneous therapy has emerged as an option for treatment of mitral regurgitation for selected, predominantly high-risk patients. Most of the percutaneous approaches are modifications of existing surgical approaches. Catheter-based devices mimic these surgical approaches with less procedural risk, due to their less-invasive nature. Percutaneous annuloplasty can be achieved indirectly via the coronary sinus or directly from retrograde left ventricular access. Catheter-based leaflet repair with the MitraClip (Abbott Laboratories, Abbott Park, Illinois) is accomplished with an implantable clip to mimic the surgical edge-to-edge leaflet repair technique. A large experience with MitraClip has been reported, and several other percutaneous approaches have been successfully used in smaller numbers of patients to demonstrate proof of concept, whereas others have failed and are no longer under development. There is increasing experience in both trials and practice to begin to define the clinical utility of percutaneous leaflet repair, and annuloplasty approaches are undergoing significant development. Transcatheter mitral valve replacement is still in early development.
Keywords: MitraClip; edge-to-edge leaflet repair; mitral regurgitation; percutaneous annuloplasty; percutaneous mitral valve repair; transcatheter mitral repair.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Percutaneous leaflet repair and annuloplasty for mitral regurgitation.J Am Coll Cardiol. 2011 Feb 1;57(5):529-37. doi: 10.1016/j.jacc.2010.10.012. J Am Coll Cardiol. 2011. PMID: 21272742 Review.
-
Percutanenous therapies for mitral regurgitation.Curr Probl Cardiol. 2012 Feb;37(2):42-68. doi: 10.1016/j.cpcardiol.2011.09.001. Curr Probl Cardiol. 2012. PMID: 22230740 Review.
-
Percutaneous transcatheter mitral valve repair: a classification of the technology.JACC Cardiovasc Interv. 2011 Jan;4(1):1-13. doi: 10.1016/j.jcin.2010.09.023. JACC Cardiovasc Interv. 2011. PMID: 21251623 Review.
-
Percutaneous Direct Annuloplasty With Edge-to-Edge Technique for Mitral Regurgitation: Replicating a Complete Surgical Mitral Repair in a One-Step Procedure.Can J Cardiol. 2018 Aug;34(8):1088.e1-1088.e2. doi: 10.1016/j.cjca.2018.04.003. Epub 2018 Apr 6. Can J Cardiol. 2018. PMID: 30056846
-
Current status and clinical development of transcatheter approaches for severe mitral regurgitation.Circ J. 2015;79(6):1164-71. doi: 10.1253/circj.CJ-15-0447. Epub 2015 May 1. Circ J. 2015. PMID: 25947004 Review.
Cited by
-
[Structure and function of the mitral valve. Eligibility criteria for surgical and interventional approaches].Herz. 2015 Jun;40(4):569-75. doi: 10.1007/s00059-015-4234-2. Herz. 2015. PMID: 25963035 Review. German.
-
Ex Vivo Model of Functional Mitral Regurgitation Using Deer Hearts.J Cardiovasc Transl Res. 2021 Jun;14(3):513-524. doi: 10.1007/s12265-020-10071-y. Epub 2020 Sep 21. J Cardiovasc Transl Res. 2021. PMID: 32959169 Free PMC article.
-
The role of transcatheter mitral valve therapy in heart failure.Eur J Cardiothorac Surg. 2019 Jun 1;55(Suppl 1):i26-i30. doi: 10.1093/ejcts/ezy410. Eur J Cardiothorac Surg. 2019. PMID: 31106334 Free PMC article. Review.
-
Directed evolution of enzymes for biocatalysis and the life sciences.Cell Mol Life Sci. 2004 Dec;61(24):3034-46. doi: 10.1007/s00018-004-4234-5. Cell Mol Life Sci. 2004. PMID: 15583865 Free PMC article. Review.
-
Site-Level Variability in 30-Day Patient Outcomes After Transcatheter Mitral Valve Repair in the United States.Circ Cardiovasc Qual Outcomes. 2020 Dec;13(12):e006878. doi: 10.1161/CIRCOUTCOMES.120.006878. Epub 2020 Dec 7. Circ Cardiovasc Qual Outcomes. 2020. PMID: 33280434 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources